Alaunos Therapeutics TCRT
NASDAQ TCRT
$1.76 -0.02 (-1.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alaunos Therapeutics (TCRT) Prepaid Assets (2009 - 2026)

Alaunos Therapeutics' (TCRT) quarterly Prepaid Assets came in at $616000.0 in Q1 2026, down 17.43% YoY from $746000.0 in Q1 2025, and up 2.67% on a QoQ basis from $600000.0 in Q4 2025.

Alaunos Therapeutics (TCRT) Prepaid Assets (2009 - 2026) Analysis & Trends

Alaunos Therapeutics (TCRT) has 18 years of Prepaid Assets data on file, last reported at $616000.0 in Q1 2026.

  • Quarterly Prepaid Assets fell 17.43% year-over-year to $616000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $616000.0 (down 17.43% YoY) and the FY2025 annual result came in at $600000.0, down 63.83% from the prior year.
  • Prepaid Assets climbed to $616000.0 in Q1 2026, from $600000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.2 million in Q2 2024 to a low of $457000.0 in Q2 2023.
  • A 5-year average of $1.2 million and a median of $857000.0 in 2025 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 80.16% — and 2024, when it jumped 383.81%.
  • Tracing TCRT's Prepaid Assets over 5 years: stood at $799000.0 in 2022, then soared by 175.09% to $2.2 million in 2023, then slipped by 24.52% to $1.7 million in 2024, then tumbled by 63.83% to $600000.0 in 2025, then rose by 2.67% to $616000.0 in 2026.
  • The last three Prepaid Assets figures came in at $616000.0 (Q1 2026), $600000.0 (Q4 2025), and $747000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Alaunos Therapeutics 4.28 Mn 4.16 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 616,000.00
Dec 31, 2025 600,000.00
Sep 30, 2025 747,000.00
Jun 30, 2025 857,000.00
Mar 31, 2025 746,000.00
Dec 31, 2024 1.66 Mn
Sep 30, 2024 1.87 Mn
Jun 30, 2024 2.21 Mn
Mar 31, 2024 1.89 Mn
Dec 31, 2023 2.20 Mn
Sep 30, 2023 925,000.00
Jun 30, 2023 457,000.00
Mar 31, 2023 750,000.00
Dec 31, 2022 799,000.00
Sep 30, 2022 849,000.00
Jun 30, 2022 1.35 Mn
Mar 31, 2022 1.52 Mn
Dec 31, 2021 1.67 Mn
Sep 30, 2021 3.32 Mn
Jun 30, 2021 5.04 Mn